BTG (BTG)

 

BTG Share PerformanceMore

52 week high784.0 28/12/17
52 week low528.4 31/01/17
52 week change 158.0 (26.83%)
4 week volume10,776,858 25/12/17

Latest NewsMore

Total Voting Rights

RNS Number: 7086A BTG PLC 02 January 2018 2 January 2018 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 2 January 2018: 1. the Company's issued share capital consists of 386,435,712 Ordinaryshares of 10p each admitted to trading, and each with one vo...

BTG holds interventional medicine seminar

BTG, the specialist healthcare company, will host an interventional medicine seminar today at the offices of Deutsche Ban...

Interventional Medicine Seminar

RNS Number: 4151Y BTG PLC 07 December 2017 BTG plc: Interventional Medicine Seminar London, UK, 7 December 2017: BTG plc (LSE: BTG), the specialist healthcare company, will host an Interventional Medicine Seminar today at 10:30am at the offices of Deutsche Bank, 1 Great Winchester Street, London, EC3N 2DB. This event will provide greater understanding...

Total Voting Rights

RNS Number: 1317Y BTG PLC 01 December 2017 1 December 2017 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 1 December 2017: 1. the Company's issued share capital consists of 386,413,796 Ordinaryshares of 10p each admitted to trading, and each with on...

BTG strengthens its board

BTG, the global specialist healthcare company, has appointed Gregory Barrett as a non-executive director. Barrett is curren...

Appointment of Non-executive Director

RNS Number: 5273X BTG PLC 27 November 2017 BTG plc: Appointment of Non-executive Director London, UK, 27 November 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announces the appointment of Gregory Barrett as a non-executive director of the Board. Greg has a broad range of commercial experience in the US medtech indus...

Broker Forecast - JP Morgan Cazenove issues a broker note on BTG PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on BTG PLC (LON:BTG) and cut its price target to 730...

Holding(s) in Company

RNS Number: 7612W BTG PLC 16 November 2017 TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: BTG PLC LEI: 213800DCVRNVRVINH968 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. Re...

Fundamental DataMore

P/E ratio85.862
EPS8.7
Dividend yield0 %

Latest discussion posts More

  • Re: Northwestern Uni Adopts TheraSpher a...

    As far as I know is that this university Hospital have been trialling the product and as I understand it they concluded it gives greater life expectancy than the present ...
    19-Jan-2018
    d gaser
  • Re: Northwestern Uni Adopts TheraSpher as first line treatment

    Hi DG, thanks for that. Any idea how important this is in the wider adoption of Theraspere as a treatment?
    19-Jan-2018
    JefH
  • Zytiga

    administrative court invalidated a Johnson & Johnson (JNJ.N) patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and ...
    19-Jan-2018
    pauloverdi

Users' HoldingsMore

Users who hold BTG also hold..
LENOVO100%
CITY MERCH.HIGH100%
3I GRP.100%
RENISHAW100%
XP POWER100%

Codes & Symbols

ISINGB0001001592
SymbolsBTG, LSE:BTG, BTG.L, BTG:LN, LON:BTG, XLON:BTG

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account